Market Exclusive

Analyst Activity – Needham & Company LLC Initiates Coverage On CTI BioPharma (NASDAQ:CTIC) (NASDAQ:CTIC) With a Buy

Analyst Ratings For CTI BioPharma (NASDAQ:CTIC) (NASDAQ:CTIC)

Today, Needham & Company LLC initiated coverage on CTI BioPharma (NASDAQ:CTIC) (NASDAQ:CTIC) with a Buy with a price target of $10.00.

Some recent analyst ratings include

Recent Insider Trading Activity For CTI BioPharma (NASDAQ:CTIC) (NASDAQ:CTIC)
CTI BioPharma (NASDAQ:CTIC) (NASDAQ:CTIC) has insider ownership of 2.16% and institutional ownership of 33.95%.

Recent Trading Activity for CTI BioPharma (NASDAQ:CTIC) (NASDAQ:CTIC)
Shares of CTI BioPharma (NASDAQ:CTIC) closed the previous trading session at 4.00 up +0.15 3.76% with 3.940000057220459 shares trading hands.

Exit mobile version